seen from Morocco
seen from Malaysia
seen from Australia
seen from France
seen from Brazil
seen from Türkiye
seen from United States
seen from Bangladesh
seen from Colombia
seen from Austria
seen from Iraq
seen from Brazil
seen from China
seen from France
seen from United States
seen from United States
seen from Venezuela
seen from China
seen from China
seen from United States
(Nasdaq:CMPR) Cimpress NV Dips To New 52 Week Low
(Nasdaq:CMPR) Cimpress NV Dips To New 52 Week Low
Cimpress NV (Nasdaq:CMPR)
January 31st, 2019 Cimpress NV fell $32.78 Thursday which equals a 28.27% drop, closing at $83.17. As well as the drop in value, Cimpress NV hit a new 52 week low of $76.76. Despite the drop in value, trading volumes were solid at 1,493% of normal which can indicate investor opportunities. (more…)
View On WordPress
Cimpress NV (Nasdaq:CMPR) Hits 52 Week Low
Cimpress NV (Nasdaq:CMPR) Hits 52 Week Low
Cimpress NV (Nasdaq:CMPR)
December 22nd, 2018 Amidst falling markets Cimpress NV fell $4.02 Friday, down 3.85%, closing at $100.35. As well as the drop in value, Cimpress NV hit a new 52 week low of $99.64, breaking the previous low of $101.99 from earlier this month. Despite the drop in value, trading volumes were solid at 212% of normal which can indicate investor opportunities. (more…)
View On WordPress
(Nasdaq:CMPR) Cimpress NV Hits 52 Week Low
(Nasdaq:CMPR) Cimpress NV Hits 52 Week Low
Cimpress NV (Nasdaq:CMPR)
December 17th, 2018 Amidst falling markets Cimpress NV fell $2.09 Monday which equals a 1.90% drop, closing at $107.96. As well as the drop in value, Cimpress NV hit a new 52 week low of $106.00, breaking the previous low of $109.00 from earlier this July. (more…)
View On WordPress
Aegis has upgraded the stock of Cimpress NV (NASDAQ:CMPR)
Aegis has upgraded the stock of Cimpress NV (NASDAQ:CMPR)
Aegis has upgraded the stock of Cimpress NV (NASDAQ:CMPR) to Hold from its previous rating of. The firm has set a target price of $85 Aegis made the following changes in ratings on the following stocks on November 30: Aegis has upgraded the stock of Globus Medical Inc. (NYSE:GMED) to Buy from its previous rating of. The firm has set a target price of $31 Aegis has upgraded the stock of NuVasive…
View On WordPress
